Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
Conditions: COVID-19; COVID-19 Drug Treatment; Severe Acute Respiratory Syndrome Coronavirus 2 Interventions: Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet; Drug: Telmisartan 40Mg Oral Tablet; Drug: Atorvastatin 20 Mg Oral Tablet Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Université de Bordeaux; Programme PACCI Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials